Literature DB >> 9295062

Allele frequency of CYP2C19 in a Portuguese population.

J L Ruas1, M C Lechner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9295062     DOI： 10.1097/00008571-199708000-00009

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN： 0960-314X


× No keyword cloud information.
  11 in total

Review 1.  Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.

Authors:  I Fricke-Galindo; C Céspedes-Garro; F Rodrigues-Soares; M E G Naranjo; Á Delgado; F de Andrés; M López-López; E Peñas-Lledó; A LLerena
Journal:  Pharmacogenomics J       Date:  2015-10-27       Impact factor: 3.550

2.  Genetic polymorphism of CYP2C19 in Maharashtrian population.

Authors:  Yogita Ghodke; Kalpana Joshi; Yashendra Arya; Anjali Radkar; Aditi Chiplunkar; Pooja Shintre; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

3.  Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.

Authors:  Fabiana B Kohlrausch; Ángel Carracedo; Mara H Hutz
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

4.  Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.

Authors:  Heydy V Bravo-Villalta; Koujirou Yamamoto; Katsunori Nakamura; Ana Bayá; Yuko Okada; Ryuya Horiuchi
Journal:  Eur J Clin Pharmacol       Date:  2005-03-18       Impact factor: 2.953

5.  Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group.

Authors:  Robabeh Ghiyas Tabari; Abdoljalal Marjani; Ogholdondy Agh Ataby; Azad Reza Mansourian; Nader Mansour Samai
Journal:  Oman Med J       Date:  2013-07

6.  Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.

Authors:  Samar Ismail Hamdy; Masahiro Hiratsuka; Kaori Narahara; Mervat El-Enany; Nadia Moursi; Mohammed Salah-Eldin Ahmed; Michinao Mizugaki
Journal:  Br J Clin Pharmacol       Date:  2002-06       Impact factor: 4.335

Review 7.  Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Authors:  Zeruesenay Desta; Xiaojiong Zhao; Jae-Gook Shin; David A Flockhart
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma.

Authors:  Achraf Khedhaier; Elham Hassen; Noureddine Bouaouina; Sallouha Gabbouj; Slim Ben Ahmed; Lotfi Chouchane
Journal:  BMC Cancer       Date:  2008-04-18       Impact factor: 4.430

9.  Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (‑806 C>T) alleles among an Iranian population of different ethnicities.

Authors:  Mahshid Dehbozorgi; Behnam Kamalidehghan; Iman Hosseini; Zahra Dehghanfard; Mohammad Hossein Sangtarash; Maryam Firoozi; Fatemeh Ahmadipour; Goh Yong Meng; Massoud Houshmand
Journal:  Mol Med Rep       Date:  2018-01-05       Impact factor: 2.952

10.  Inconsistency in race and ethnic classification in pharmacogenetics studies and its potential clinical implications.

Authors:  Frederick Zhang; Joseph Finkelstein
Journal:  Pharmgenomics Pers Med       Date:  2019-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.